Hier sehen Sie eine Übersicht über alle von der Universitäts-Hautklinik angebotenen Veranstaltungen und deren Termine. Unter "zur Veranstaltung" finden Sie jeweils eine ausführliche Beschreibung mit Informationen über den Inhalt und die Formalitäten.
Dear collegues,
twelve years after the introduction of endovenous laser
treatment to Germany, we will meet at the same place to
discuss the latest innovation in the field of saphenous vein
reflux abolition: Endovenous Cyanoacrylate Adhesive.
With a „no-tumescent-no- compression-stocking“ treatment
we are facing another game change in the treatment of incompetent
saphenous veins. Since its introduction to Europe
in September 2011 the Sapheon VenaSeal technology has
found its way into the scientific literature at its highest level.
We look forward to live surgery, presentation of clinical experience
of VenaSeal users and discussion of the latest clinical
studies with an highly interested audience.
Yours sincerely
Prof. Dr. Thomas M. Proebstle
Datum | Samstag 26. Januar 2013 |
---|---|
Uhrzeit | 10:00 - 14:00 Uhr |
Ort | Hörsaal Hautklinik Gebäude 401 |
Dozent/in | Dr. Jens Alm Director Vascular Surgery Unit Dermatologikum Hamburg
Dr. Bettina Kleis-Fischer Director Dermatologic Surgery Dept. of Dermatology, University Medical Center Mainz
Prof. Dr. Thomas Proebstle, Dept. of Dermatology University Medical Center Mainz Privatklinik Proebstle GmbH
Dr. Rod Raabe, Chief Medical Officer, Chairman of the Board Sapheon Inc Santa Rosa, California, USA
Dr. Ulf Zierau SAPHENION Praxisklinik |
Fortbildungspunkte | CME Ärztekammer Rheinhessen (5 Punkte) |
Anmeldeschluss | Sonntag 20. Januar 2013 |
Kontakt | Elvira Lennartz, Hautklinik |
Downloads | Flyer-1stendovenousabolition.pdf |